LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Recruiting · NCT07234695 · Registry updated 2026-01-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome | Abnormalities, Multiple, Alzheimer disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Epilepsy, Generalized, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, chromosomal disorder, cognitive disorder, dementia, epilepsy, epilepsy with generalized tonic-clonic seizures, hereditary disease, intellectual disability, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, visual epilepsy | Recruiting | Phase 3 | 2026-01-12 | NCT07234695 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fundación CITA Alzheimer | Donostia / San Sebastian | Spain | 1 |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | 20 |
| Hospital La Princesa | Madrid | Spain | 10 |
| Hospital Universitario Marqués de Valdecilla | Santander | Spain | 40 |
| Hospital Virgen de las Nieves | Granada | Spain | 2 |